aripiprazole has been researched along with Atherosclerotic Parkinsonism in 10 studies
| Timeframe | Studies, this research(%) | All Research% |
|---|---|---|
| pre-1990 | 0 (0.00) | 18.7374 |
| 1990's | 0 (0.00) | 18.2507 |
| 2000's | 0 (0.00) | 29.6817 |
| 2010's | 9 (90.00) | 24.3611 |
| 2020's | 1 (10.00) | 2.80 |
| Authors | Studies |
|---|---|
| Chakrabarti, SS; Gambhir, IS; Kaur, U; Ojha, B; Pathak, BK; Singh, A | 1 |
| Blumberger, DM; Hsu, JH; Karp, JF; Lenze, EJ; Mulsant, BH; Reynolds, CF; Sanches, M | 1 |
| Belletti, A; Cilia, R; Marotta, G; Pezzoli, G; Siri, C | 1 |
| Al-Jadiri, A; Azzo, S; Carbon, M; Correll, CU; Kane, JM; Kapoor, S; Saito, E; Sarkaria, T; Sheridan, E | 1 |
| Anderson, SJ; Begley, AE; Blumberger, DM; Butters, MA; Dew, MA; Karp, JF; Lenze, EJ; Mulsant, BH; Newcomer, JW; Reynolds, CF; Stack, JA | 1 |
| Chen, YW; Tseng, PT | 1 |
| Chouinard, S; Huot, P; Selfani, K; Soland, VL | 1 |
| Albayrak, Y; Caykoylu, A; Ekinci, O; Ugurlu, GK | 1 |
| Ishitobi, M; Kosaka, H; Murata, T; Oonuma, M; Takahashi, T; Wada, Y | 1 |
| Miranda C, M; Retamal C, P | 1 |
1 review(s) available for aripiprazole and Atherosclerotic Parkinsonism
| Article | Year |
|---|---|
A Review of Differences in Clinical Characteristics between Tardive Syndrome Induced or Improved by Aripiprazole Treatment.
Topics: Antipsychotic Agents; Aripiprazole; Dystonia; Humans; Parkinson Disease, Secondary; Psychotic Disorders; Tardive Dyskinesia | 2016 |
2 trial(s) available for aripiprazole and Atherosclerotic Parkinsonism
| Article | Year |
|---|---|
Clinical Predictors of Extrapyramidal Symptoms Associated With Aripiprazole Augmentation for the Treatment of Late-Life Depression in a Randomized Controlled Trial.
Topics: Aged; Akathisia, Drug-Induced; Antidepressive Agents; Aripiprazole; Depressive Disorder, Treatment-Resistant; Female; Humans; Late Onset Disorders; Male; Parkinson Disease, Secondary; Risk Factors; Time Factors | 2018 |
Efficacy, safety, and tolerability of augmentation pharmacotherapy with aripiprazole for treatment-resistant depression in late life: a randomised, double-blind, placebo-controlled trial.
Topics: Aged; Akathisia, Drug-Induced; Antidepressive Agents; Aripiprazole; Depressive Disorder, Treatment-Resistant; Double-Blind Method; Drug Administration Schedule; Female; Humans; Male; Middle Aged; Parkinson Disease, Secondary; Recurrence; Treatment Outcome | 2015 |
7 other study(ies) available for aripiprazole and Atherosclerotic Parkinsonism
| Article | Year |
|---|---|
Aripiprazole-induced Parkinsonism with pregabalin as a confounder.
Topics: Antipsychotic Agents; Aripiprazole; Humans; Male; Middle Aged; Parkinson Disease, Secondary; Pregabalin | 2021 |
Reversible dopamine transporter reduction in drug-induced Parkinsonism.
Topics: Aged; Aripiprazole; Bipolar Disorder; Brain; Dopamine Plasma Membrane Transport Proteins; Female; Humans; Lithium Carbonate; Parkinson Disease, Secondary; Piperazines; Quinolones; Radionuclide Imaging | 2014 |
Neuromotor Adverse Effects in 342 Youth During 12 Weeks of Naturalistic Treatment With 5 Second-Generation Antipsychotics.
Topics: Adolescent; Akathisia, Drug-Induced; Antipsychotic Agents; Aripiprazole; Benzodiazepines; Child; Drug Therapy, Combination; Dyskinesia, Drug-Induced; Female; Humans; Male; Mental Disorders; Multivariate Analysis; New York; Olanzapine; Parkinson Disease, Secondary; Piperazines; Prospective Studies; Quetiapine Fumarate; Regression Analysis; Risperidone; Thiazoles | 2015 |
Movement Disorders Induced by the "Atypical" Antipsychotic Aripiprazole.
Topics: Adult; Aged; Akathisia, Drug-Induced; Antipsychotic Agents; Aripiprazole; Female; Humans; Male; Middle Aged; Parkinson Disease, Secondary; Tardive Dyskinesia; Young Adult | 2017 |
Aripiprazole-associated bruxism, akathisia, and parkinsonism in a bipolar patient.
Topics: Akathisia, Drug-Induced; Aripiprazole; Bipolar Disorder; Bruxism; Female; Humans; Parkinson Disease, Secondary; Piperazines; Quinolones; Young Adult | 2011 |
Aripiprazole monotherapy in the treatment of vascular parkinsonism.
Topics: Aged; Antipsychotic Agents; Aripiprazole; Female; Humans; Parkinson Disease, Secondary; Piperazines; Psychotic Disorders; Quinolones; Treatment Outcome | 2011 |
[Potentiation of Aripiprazole extrapiramidal adverse effects with the concomitant use of serotonin selective reuptake inhibitors].
Topics: Adult; Antipsychotic Agents; Aripiprazole; Drug Therapy, Combination; Female; Humans; Male; Middle Aged; Parkinson Disease; Parkinson Disease, Secondary; Piperazines; Quinolones; Selective Serotonin Reuptake Inhibitors | 2011 |